Similar articles

• Baroreflex effectiveness index and baroreflex sensitivity predict all-cause mortality and sudden death in hypertensive patients with chronic renal failure.

  Johansson M, Gao SA, Friberg P, Annerstedt M, Carlström J, Ivarsson T, Jensen G, Ljungman S, Mathillas O, Nielsen FD, Strömbom U. Johansson M, et al. J Hypertens. 2007 Jan;25(1):163-8. doi: 10.1097/01.hjh.0000254377.18983.eb. J Hypertens. 2007. PMID: 17143188
• Heart rate variability in patients with end-stage renal disease: an emerging predictive tool for sudden cardiac death?

  Chan CT. Chan CT. Nephrol Dial Transplant. 2008 Oct;23(10):3061-2. doi: 10.1093/ndt/gfn280. Epub 2008 May 23. Nephrol Dial Transplant. 2008. PMID: 18503010 Review. No abstract available.
• How to measure baroreflex sensitivity: from the cardiovascular laboratory to daily life.

  Parati G, Di Rienzo M, Mancia G. Parati G, et al. J Hypertens. 2000 Jan;18(1):7-19. J Hypertens. 2000. PMID: 10678538 Review.
• Heart rate as independent prognostic factor for mortality in normotensive hemodialysed patients.

  Cice G, Di Benedetto A, D'Andrea A, D'Isa S, De Gregorio P, Marcelli D, Gatti E, Calabrò R. Cice G, et al. J Nephrol. 2008 Sep-Oct;21(5):704-12. J Nephrol. 2008. PMID: 18949725
• The functional cardiovascular consequences of vascular calcification.

  McIntyre CW. McIntyre CW. Semin Dial. 2007 Mar-Apr;20(2):122-8. doi: 10.1111/j.1525-139X.2007.00258.x. Semin Dial. 2007. PMID: 17374085 Review.